id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0656-0026,FDA,FDA-2011-N-0656,ADUFA Reauthorization Performance Goals and Procedures – FYs 2019 thru 2023,Other,Letter(s),2017-11-01T04:00:00Z,2017,11,2017-11-01T04:00:00Z,,2017-11-01T17:01:01Z,,0,0,0900006482c3127e
FDA-2011-N-0656-0027,FDA,FDA-2011-N-0656,ADUFA IV Summary of the Proposed Changes to the FD&C Act and Proposed Bill Language,Other,Letter(s),2017-11-01T04:00:00Z,2017,11,2017-11-01T04:00:00Z,,2017-11-01T17:03:13Z,,0,0,0900006482c30f86
FDA-2011-N-0656-0024,FDA,FDA-2011-N-0656,AGDUFA III Summary of the Proposed Changes to the FDC Act and Proposed,Other,,2017-11-01T00:00:00Z,2017,11,,,2017-11-01T16:30:30Z,,0,1,0900006482c30d31
FDA-2011-N-0656-0025,FDA,FDA-2011-N-0656,Animal Generic Drug User Fee Act Reauthorization Performance Goals and Procedures,Other,,2017-11-01T00:00:00Z,2017,11,,,2017-11-01T17:01:51Z,,0,1,0900006482c30d32
FDA-2011-N-0656-0023,FDA,FDA-2011-N-0656,Animal Drug User Fee Act; Recommendations; Request for Comments; Extension of Comment Period,Notice,Extension of Comment Period,2017-10-25T04:00:00Z,2017,10,2017-10-25T04:00:00Z,2017-11-25T04:59:59Z,2017-11-23T02:02:21Z,2017-23172,0,0,0900006482c0230f
FDA-2011-N-0656-0022,FDA,FDA-2011-N-0656,Animal Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2017-10-05T04:00:00Z,2017,10,2017-10-05T04:00:00Z,,2017-10-05T14:34:39Z,2017-21439,0,0,0900006482b9f568